Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study-Reference-Cited by-同舟云学术

Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study

Published:2021-07-04 Issue:3 Volume:8 Page:1241-1253
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Doaré Elise,Robin François,Racapé Hélène,Le Mélédo Guillaume,Orione Charles,Guggenbuhl Pascal,Goupille Philippe,Gervais Elisabeth,Dernis Emmanuelle,Bouvard Béatrice,Marhadour Thierry,Coiffier Guillaume,Saraux Alain

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s40744-021-00335-7.pdf

Reference27 articles.

1. Choi H. Epidemiology of crystal arthropathy. Rheum Dis Clin North Am. 2006;32(2):255–73. https://doi.org/10.1016/j.rdc.2006.03.002 (v).

2. Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. https://doi.org/10.1136/annrheumdis-2016-209707.

3. Khanna D, Khanna PP, FitzGerald JD, et al. 2012 American College of Rheumatology guidelines for management of gout part II: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. 2012;64(10):1447–61. https://doi.org/10.1002/acr.21773.

4. Latourte A, Pascart T, Flipo R-M, et al. 2020 Recommendations from the French Society of Rheumatology for the management of gout: management of acute flares. Joint Bone Spine. 2020;87(5):387–93. https://doi.org/10.1016/j.jbspin.2020.05.001.

5. Keenan RT, O’Brien WR, Lee KH, et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011;124(2):155–63. https://doi.org/10.1016/j.amjmed.2010.09.012.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature;Frontiers in Medicine;2023-01-12

2. CPPD and Other Microcrystalline Disorders;A Clinician's Pearls & Myths in Rheumatology;2023

3. Use of anakinra in treatment of combination of calcium pyrophosphate deposition desease and gout (clinical observation);Medical alphabet;2022-07-25

4. The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist);Rheumatology Science and Practice;2022-07-01